Foundation Medicine Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. | Trans Genic Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities. | |||
Founding Date | Founding Date 2010 | Founding Date 2005 | Founding Date 1991 | Founding Date 1998 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Boston, US HQ Penzberg, DE Morrisville, US San Diego, US | Locations Boulder, US HQ De Soto, US | Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH | Locations Chiyoda City, JP HQ |
Employees | Employees 1,8031% decrease | Employees 21711% decrease | Employees 2,700 | Employees 236 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 239.5 m | Valuation ($) 2 b | Valuation ($) 25.6 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $152.9m (FY, 2017) | Revenue (est.) $88.5m (FY, 2025) | Revenue (est.) $824.5m (FY, 2025) | Revenue (est.) ¥13.2b (FY, 2026) |
Cost of goods | Cost of goods $85.3m (FY, 2017) | Cost of goods N/A | Cost of goods $247.9m (FY, 2025) | Cost of goods ¥10.6b (FY, 2026) |
Gross profit | Gross profit $67.6m (FY, 2017) | Gross profit N/A | Gross profit $576.6m (FY, 2025) | Gross profit ¥2.6b (FY, 2026) |
Net income | Net income ($161.5m) (FY, 2017) | Net income ($35.3m) (FY, 2025) | Net income ($365.9m) (FY, 2025) | Net income (¥97.5m) (FY, 2026) |
Operating ⚠ | ||||
Products | Products 3 (Jul, 2022) | Products N/A | Products 10 (FY, 2021) | Products N/A |
Funding | ||||
Total funding raised | Total funding raised $ 96.5m | Total funding raised $ 98.2m | Total funding raised N/A | Total funding raised N/A |
Biodesix is a company that provides data-driven diagnostic solutions.
View companyMyriad Genetics is a company that develops and offers genetic tests.
View companyTrans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.
View company